Semiquantitative scoring in children under treatment for atopic dermatitis

Murao, Yoshinori; Mae, Hiromu; Konishi, T.; Gao, Xiaojie; Tanizawa, Takakuni

doi:10.1111/j.1442-200x.2004.01885.x

Cited by 9 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent systematic review on the validation of AD outcome measures identified 16 different AD severity scales . Five of the most commonly used include Scoring Atopic Dermatitis (SCORAD), Eczema Area and Severity Index (EASI), Six Areas, Six Sites Atopic Dermatitis (SASSAD), Three Item Severity index (TIS) and the Patient‐Oriented Eczema Measure (POEM) .…”

mentioning

confidence: 99%

A pilot comparison study of four clinician‐rated atopic dermatitis severity scales

et al. 2015

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

A pilot comparison study of four clinician‐rated atopic dermatitis severity scales

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Associations with allergic and non-allergic comorbidities are being increasingly reported in moderate to severe AD. Murao et al 30 have suggested that the severity of AD should be measured by adding scores based on complications of each patient. Similarly, the Singapore Guideline recommends that AD patients with psychological dysfunction should be treated as severe AD 28 .…”

Section: Discussionmentioning

confidence: 99%

2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity

et al. 2019

View full text Add to dashboard Cite

Background: Systemic immunomodulatory treatment is actively recommended in the treatment for moderate to severe atopic dermatitis (AD) patients. However, consensus criteria for the classification of AD severity or treatment refractoriness have not been established yet. Objective: To establish consensus criteria on the definition of severity classification and treatment refractoriness of AD to provide a basis for proper treatment strategy. Methods: The Korean Atopic Dermatitis Association (KADA) comprised a task force team to establish a definition of moderate to severe AD. A draft of definition of moderate to severe AD was made on the basis of evidence. The recommendation was confirmed by KADA members through a web-based survey. Results: KADA approved that AD with 16≤eczema area and severity index (EASI)＜23 should be basically defined as moderate AD whereas AD with EASI score ≥23 should be considered as severe AD. They agreed that it would be reasonable to raise the severity level if patient's daytime or nighttime pruritus numerical rating scale is equal to or higher than 7 (≥7) or dermatology life quality index score exceeds 10. AD patients who do not reach EASI 50 after appropriate treatment for three months should be considered as a non-responder. Patients with recurrence (EASI ≥16) within three months after cessation of treatment should be considered as a recurrent AD. Conclusion: KADA built a consensus of definition of moderate and severe AD and treatment-refractoriness. These guidelines are expected to help physicians determine proper treatment options in need. (Ann Dermatol 31(6) 654∼661, 2019

show abstract

Atopic Dermatitis Outcome Measures

Zhao,

Murrell

2024

Cutaneous Biometrics

View full text Add to dashboard Cite

Semiquantitative scoring in children under treatment for atopic dermatitis

Abstract: Use of well-constructed scoring forms should improve clinical assessment of patient course and treatment response.

Cited by 9 publications

References 3 publications

A pilot comparison study of four clinician‐rated atopic dermatitis severity scales

A pilot comparison study of four clinician‐rated atopic dermatitis severity scales

2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity

Atopic Dermatitis Outcome Measures

Contact Info

Product

Resources

About